Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity
- 1 June 1977
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 7 (3) , 181-187
- https://doi.org/10.1111/j.1365-2362.1977.tb01595.x
Abstract
As in women receiving estrogens [e.g., oral contraceptives] the administration of 17.beta.-estradiol to ovariectomized female rats caused a rise in fasting plasma triglycerides and a fall in plasma glucose. Progesterone, on the other hand, had no significant effects. In the estradiol treated rats, the portal vein basal insulin levels were slightly reduced. Estradiol had a marked suppressive effect on the .alpha. cells of the pancreas resulting in a greater reduction in basal glucagon and impaired glucagon response to alanine infusions. The relative insulin to glucagon (I/G) molar concentration ratio in portal vein blood was increased. Estradiol also produced a dose dependent increase in the activity of the liver lipogenic enzymes, acetyl CoA carboxylase and fatty acid synthetase. On the other hand, the activity of the gluconeogenic rate limiting enzyme phosphoenol-pyruvate carboxykinase (PEPCK) was inhibited. The cross-over pattern of gluconeogenic intermediates confirmed inhibition of gluconeogenesis at this step, an effect which is similar to that induced by relative insulin excess. Progesterone produced an increase in the portal vein insulin concentrations. Both the basal and the alanine-stimulated glucagon levels were also increased. The I/G molar ratio in portal vein blood of progesterone treated rats remained unaltered and the hepatic lipogenic and gluconeogenic enzyme activities were similar to control animals. These data suggest that insulin activity is increased relative to glucagon in the liver of estradiol-treated rats due to the rise in portal vein I/G ratio. The changes in liver lipogenic and gluconeogenic enzymes and the alterations in fasting plasma triglycerides and glucose in response to estrogens could be secondary to this effect. [Risk of cardiovascular disease upon taking oral contraceptives is discussed.].Keywords
This publication has 30 references indexed in Scilit:
- OESTROGEN INDUCED HYPERTRIGLYCERIDAMIA: ROLE OF THE ADRENAL CORTEXClinical Endocrinology, 1976
- THE EFFECTS OF A PROGESTOGEN, MEGESTROL ACETATE, ON CARBOHYDRATE AND LIPID METABOLISMBJOG: An International Journal of Obstetrics and Gynaecology, 1972
- Effect of muscular exercise and glycogen depletion on rat liver and kidney phosphoenolpyruvate carboxykinaseFEBS Letters, 1971
- SERUM-LIPIDS IN WOMEN ON ORAL CONTRACEPTIVESThe Lancet, 1971
- Hepatic metabolism of free fatty acids in normal and diabetic dogsJournal of Clinical Investigation, 1970
- ORAL CONTRACEPTIVES AND GLUCOSE TOLERANCEThe Lancet, 1969
- New automated method for measuring glucose by glucose oxidaseJournal of Clinical Pathology, 1967
- Gluconeogenesis in the perfused liverThe American Journal of Medicine, 1966
- Incorporation of malonyl CoA into fatty acids by liver in starvation and alloxan-diabetesBiochemical and Biophysical Research Communications, 1960
- Studies on the mechanism of fatty acid synthesis VI. Spectrophotometric assay and stoichiometry of fatty acid synthesisBiochimica et Biophysica Acta, 1959